Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies

• Status: Withdrawn
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Will patients that receive injections of Marcaine into the uterine nerve via the uterosacral ligaments experience less pain postoperatively, need less narcotic pain medication and return to activities of daily living sooner.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Souza, Amanda, M.D.
• Treatments: Bupivacaine; Epinephrine; Epinephryl borate; Racepinephrine

Criteria

Inclusion Criteria:

• Patients undergoing robotically assisted total hysterectomies with cystoscopy and with or without procedures involving the adnexa (salpingectomies and salpingo-oophorectomies)

Exclusion Criteria:

• Patients undergoing single incision procedures, those having supracervical hysterectomies and additional procedures involving their pelvic floor (including bladder neck suspension, anterior colophorraphy, posterior colophorraphy, perinealplasty) and sacracolpopexy

• Patients with allergies to bupivacaine and its derivatives

• Patients taking monoamine oxidase inhibitors or tricyclic antidepressants

• Patients with known clinically significant hepatic, gastrointestinal, renal, haematological, urologic, neurological, respiratory, endocrine or cardiovascular system abnormalities

• Patients with abnormal ECG's and prolonged QT syndrome

• Patients who are currently requiring narcotic pain medication or use narcotic pain medications regularly (more than twice weekly)